J0799
HCPCSHiv prep, fda approved, noc
Official HCPCS Level II long descriptor
Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
HCPCS Level II code J0799 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Hiv prep, fda approved, noc
Added to HCPCS: 2024-01-02
Nearby codes in J0
- J0750Hiv prep, ftc/tdf 200/300mg
- J0751Hiv prep, ftc/taf 200/25mg
- J0752Hiv prep, oral lenacapavir
- J0759Inj, clevidipine, 1 mg
- J0770Colistimethate sodium inj
- J0775Collagenase, clost hist inj
- J0780Prochlorperazine injection
- J0791Inj crizanlizumab-tmca 5mg
- J0801Inj. acthar gel to 40 units
- J0802Inj. (ani), up to 40 units
- J0834Inj., cosyntropin, 0.25 mg
- J0840Crotalidae poly immune fab
- J0841Inj crotalidae im f(ab')2 eq
- J0850Cytomegalovirus imm iv /vial
- J0870Injection, imetelstat, 1 mg
- J0872Daptomycin (xellia) unrefrig
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.